Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Angela Asquino
Observed names:
ASQUINO, ANGELA,
Asquino, Angela
Institution:
Sapienza University of Rome
Observed institution:
Sapienza University of Rome
ORCID:
0000-0001-8048-249X
Observed ORCID:
0000-0001-8048-249X
OpenAlex ID:
A5092090169
CD137+ and regulatory T cells as independent prognostic factors of survival in advanced non-oncogene addicted NSCLC patients treated with immunotherapy as first-line
2024
·
Alain Gelibter
, Angela Asquino
, et al.
·
Journal of Translational Medicine
·
23
PDF
Targeting FGFRs by pemigatinib induces G1 phase cell cycle arrest, cellular stress and upregulation of tumor suppressor microRNAs
2023
·
Angelica Pace
, Fabio Scirocchi
, et al.
·
Journal of Translational Medicine
·
19
PDF
Anti-PD1 therapies induce an early expansion of Ki67+CD8+ T cells in metastatic non-oncogene addicted NSCLC patients
2024
·
Alain Gelibter
, Lucrezia Tuosto
, et al.
·
Frontiers in Immunology
·
13
PDF
Circulating CD137⁺Treg cells and LOX-1⁺PMN-MDSCs as biomarkers of immunotherapy resistance in (R/M) HNSCC patients
2025
·
Angela Asquino
, Alessio Cirillo
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
10
PDF
HHV-6A Infection of Papillary Thyroid Cancer Cells Induces Several Effects Related to Cancer Progression
2023
·
Stefania Mardente
, Maria Anele Romeo
, et al.
·
Viruses
·
6
PDF
Exploration of miR-326 delivery via biocompatible polymeric nanoparticles in medulloblastoma: A preliminary study
2026
·
Elena Splendiani
, Gabriele Maiorano
, et al.
·
Molecular Therapy — Nucleic Acids
·
2
The immunological fitness of NSCLC patients drives the response to anti-PD1-based immunotherapy regardless of age
2026
·
Lucrezia Tuosto
, Alain Gelibter
, et al.
·
Journal of Translational Medicine
·
1
PO:01:008 Treg subpopulations in patients with systemic lupus erythematosus: a possible role as biomarkers for disease activity
2026
·
Fulvia Ceccarelli
, Valeria Moretti
, et al.
·
Lupus Science & Medicine
PDF
Investigating circulating immunosuppression as novel biomarker and potential therapeutic target to overcome immunotherapy resistance in (R/M) HNSCC patients
2026
·
ASQUINO, ANGELA
·
IRIS Research product catalog (Sapienza University of Rome)
Resting T regulatory cells as biomarkers for disease activity in Systemic Lupus Erythematosus patients: results from a monocentric cohort.
2026
·
Valeria Moretti
, Angela Asquino
, et al.
·
IRIS Research product catalog (Sapienza University of Rome)
C-Type Lectin Receptors CLEC4A and CLEC12A on Peripheral Myeloid Cells Are Inversely Associated with Cancer Patients Prognosis
2026
·
Angelica Pace
, Angela Asquino
, et al.
·
IRIS Research product catalog (Sapienza University of Rome)
C-type lectins CLEC4A and CLEC12A on circulating myeloid cells as prognostic biomarkers in cancer patients
2026
·
Angelica Pace
, Angela Asquino
, et al.
·
IRIS Research product catalog (Sapienza University of Rome)
The soluble form of LAG-3 negatively impacts the clinical outcomes of (R/M) HNSCC patients receiving immunotherapy as first-line treatment
2026
·
Angela Asquino
, Alessio Cirillo
, et al.
·
IRIS Research product catalog (Sapienza University of Rome)
Immunological Network Signature of Naïve Non-Oncogene-Addicted Non-Small Cell Lung Cancer Patients Treated with Anti-PD1 Therapy: A Pilot Study
2025
·
Pasquale Sibilio
, Ilaria Grazia Zizzari
, et al.
·
Cancers
Show more works
View as search
Works count:
25
Citation count:
75
H-index:
5
I10-index:
4
Year
Topic
Type